Observational studyJAMA network open2022

Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With Polyangiitis.

Xavier Puéchal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.